Breaking News

Quintiles, OmniComm Ink TrialOne Agreement

To standardize global Phase I clinics on TrialOne technology

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Quintiles Transnational has signed a five-year agreement with OmniComm Systems for its TrialOne technology for Phase I clinic automation. The TrialOne software replaces Quintiles legacy Phase I Clinical Trial Development System (PICTS), and is part of a company-wide initiative to standardize global Phase I clinics on a single technology aimed at increasing performance, functionality and better decision-making tools.   TrialOne will be deployed at ECD clinics in the U.S. and UK, and will be integ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters